These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 19658353)

  • 1. [BRCA 1 and BRCA 2 gens in breast cancer].
    Habibović S; Hrgović Z
    Lijec Vjesn; 1998; 120(10-11):342-8. PubMed ID: 19658353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of BRCA1 and BRCA2 genes in hereditary breast cancer].
    Habibović S; Bukvić I; Hrgović Z
    Med Arh; 1999; 53(1):7-12. PubMed ID: 10356923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double heterozygotes for non-Caucasian families with mutations in BRCA-1 and BRCA-2 genes.
    Choi DH; Lee MH; Haffty BG
    Breast J; 2006; 12(3):216-20. PubMed ID: 16684319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Function of BRCA1 and BRCA2 genes associated with hereditary predisposition to breast cancer].
    Jasińska A; Krzyzosiak WJ
    Postepy Biochem; 2001; 47(2):146-59. PubMed ID: 11757317
    [No Abstract]   [Full Text] [Related]  

  • 5. Missense mutations in the BRCT domain of BRCA-1 from high-risk women frequently perturb strongly hydrophobic amino acids conserved among mammals.
    Figge MA; Blankenship L
    Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):1037-41. PubMed ID: 15184261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical treatment planning in newly diagnosed breast cancer patients at high risk for BRCA-1 or BRCA-2 mutation.
    Chung MA; Cady B
    Breast J; 2004; 10(6):473-4. PubMed ID: 15569200
    [No Abstract]   [Full Text] [Related]  

  • 7. Oral contraceptive use and BRCA penetrance: a case-only study.
    Pasanisi P; Hédelin G; Berrino J; Chang-Claude J; Hermann S; Steel M; Haites N; Hart J; Peled R; Gafà L; Leggio L; Traina A; Amodio R; Primic-Zakelj M; Zadnik V; Veidebaum T; Tekkel M; Berrino F
    Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2107-13. PubMed ID: 19549808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogenic loss of BRCA in breast cancer: the "two-hit" hypothesis takes a hit.
    Meric-Bernstam F
    Ann Surg Oncol; 2007 Sep; 14(9):2428-9. PubMed ID: 17406948
    [No Abstract]   [Full Text] [Related]  

  • 9. Breast cancer risk in relation to the joint effect of BRCA mutations and diet diversity.
    Ghadirian P; Narod S; Fafard E; Costa M; Robidoux A; Nkondjock A
    Breast Cancer Res Treat; 2009 Sep; 117(2):417-22. PubMed ID: 19165595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma.
    Rabban JT; Barnes M; Chen LM; Powell CB; Crawford B; Zaloudek CJ
    Am J Surg Pathol; 2009 Aug; 33(8):1125-36. PubMed ID: 19440148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unraveling the next chapter: sexual development, body image, and sexual functioning in female BRCA carriers.
    Matloff ET; Barnett RE; Bober SL
    Cancer J; 2009; 15(1):15-8. PubMed ID: 19197168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the performance of models for predicting the BRCA germline mutations in Han Chinese familial breast cancer patients.
    Rao NY; Hu Z; Yu JM; Li WF; Zhang B; Su FX; Wu J; Shen ZZ; Huang W; Shao ZM
    Breast Cancer Res Treat; 2009 Aug; 116(3):563-70. PubMed ID: 18807178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on genetic predisposition to breast cancer.
    Ahmed M; Lalloo F; Evans DG
    Expert Rev Anticancer Ther; 2009 Aug; 9(8):1103-13. PubMed ID: 19671030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammary tumor development in dogs is associated with BRCA1 and BRCA2.
    Rivera P; Melin M; Biagi T; Fall T; Häggström J; Lindblad-Toh K; von Euler H
    Cancer Res; 2009 Nov; 69(22):8770-4. PubMed ID: 19887619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disparities in BRCA testing: when insurance coverage is not a barrier.
    Olaya W; Esquivel P; Wong JH; Morgan JW; Freeberg A; Roy-Chowdhury S; Lum SS
    Am J Surg; 2009 Oct; 198(4):562-5. PubMed ID: 19800469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variation in IGF-1 and breast cancer risk in Ashkenazi carriers and noncarriers of BRCA1/2 mutations.
    Khoury-Shakour S; Lejbkowicz F; Barnett-Griness O; Tamir A; Pinchev M; Rennert G
    Eur J Cancer Prev; 2009 Sep; 18(5):361-7. PubMed ID: 19543094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of breast cancer among French-Canadian women, noncarriers of more frequent BRCA1/2 mutations and consumption of total energy, coffee, and alcohol.
    Bissonauth V; Shatenstein B; Fafard E; Maugard C; Robidoux A; Narod S; Ghadirian P
    Breast J; 2009; 15 Suppl 1():S63-71. PubMed ID: 19775332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic counseling and the advanced practice oncology nursing role in a hereditary cancer prevention clinic: hereditary breast cancer focus (part I).
    Snyder CL; Lynch JF; Lynch HT
    Breast J; 2009; 15 Suppl 1():S2-10. PubMed ID: 19775325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recall of and reactions to a surgeon referral letter for BRCA genetic counseling among high-risk breast cancer patients.
    Vadaparampil ST; Quinn GP; Miree CA; Brzosowicz J; Carter B; Laronga C
    Ann Surg Oncol; 2009 Jul; 16(7):1973-81. PubMed ID: 19408048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No association of miscarriage and BRCA carrier status in Pakistani breast/ovarian cancer patients with a history of parental consanguinity.
    Rashid MU; Torres D; Rasheed F; Sultan F; Shakoori AR; Amin A; Schlaefer K; Hamann U
    Breast Cancer Res Treat; 2009 Jul; 116(1):211-3. PubMed ID: 18574689
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.